ISSN 0303-5212
 

Original Research 
RMJ. 2025; 50(2): 270-273


Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study

Hafiza Momna, Kaneez Fatima, Sajjan Iqbal Memon, Mobeen Ijaz, Mehak Ahsan, Laiba Khan.


Abstract
Objective: To assess the prevalence, severity, and impact of urinary incontinence (UI) in patients receiving HTN therapy.
Methodology: This descriptive cross-sectional study was conducted in six healthcare facilities in District Gujranwala, Pakistan, with 302 participants (aged 40–60) on antihypertensive therapy for at least five years. Using convenience sampling, UI prevalence and severity were assessed using the ICIQ-SF Questionnaire. Data were analyzed in SPSS 24.0, with chi-square tests identifying significant associations (p<0.05) between gender, frequency, impact, timing, and severity of urinary leakage.
Results: We found a prevalence rate of 35%, with stress UI being the most common type. We also identified significant correlations between gender and UI (p=0.008), as well as the frequency of leakage, its impact on daily activities, the timing of leakage, and ICIQ-SF scores (all p=0.000). More than 50% reported no urine leakage or disruption in their daily activities, whereas the other participants exhibited different levels of severity and frequency.
Conclusion: These findings underscore the necessity for tailored strategies for dealing with UI, highlighting variations among different populations in hypertensive patients.

Key words: Anti-hypertensive drugs, ICIQ UI-SF, middle-aged adults, urinary incontinence.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Hafiza Momna
Articles by Kaneez Fatima
Articles by Sajjan Iqbal Memon
Articles by Mobeen Ijaz
Articles by Mehak Ahsan
Articles by Laiba Khan
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Momna H, Fatima K, Memon SI, Ijaz M, Ahsan M, Khan L. Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. RMJ. 2025; 50(2): 270-273.


Web Style

Momna H, Fatima K, Memon SI, Ijaz M, Ahsan M, Khan L. Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. https://www.rmj.org.pk/?mno=240840 [Access: May 12, 2025].


AMA (American Medical Association) Style

Momna H, Fatima K, Memon SI, Ijaz M, Ahsan M, Khan L. Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. RMJ. 2025; 50(2): 270-273.



Vancouver/ICMJE Style

Momna H, Fatima K, Memon SI, Ijaz M, Ahsan M, Khan L. Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. RMJ. (2025), [cited May 12, 2025]; 50(2): 270-273.



Harvard Style

Momna, H., Fatima, . K., Memon, . S. I., Ijaz, . M., Ahsan, . M. & Khan, . L. (2025) Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. RMJ, 50 (2), 270-273.



Turabian Style

Momna, Hafiza, Kaneez Fatima, Sajjan Iqbal Memon, Mobeen Ijaz, Mehak Ahsan, and Laiba Khan. 2025. Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. Rawal Medical Journal, 50 (2), 270-273.



Chicago Style

Momna, Hafiza, Kaneez Fatima, Sajjan Iqbal Memon, Mobeen Ijaz, Mehak Ahsan, and Laiba Khan. "Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study." Rawal Medical Journal 50 (2025), 270-273.



MLA (The Modern Language Association) Style

Momna, Hafiza, Kaneez Fatima, Sajjan Iqbal Memon, Mobeen Ijaz, Mehak Ahsan, and Laiba Khan. "Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study." Rawal Medical Journal 50.2 (2025), 270-273. Print.



APA (American Psychological Association) Style

Momna, H., Fatima, . K., Memon, . S. I., Ijaz, . M., Ahsan, . M. & Khan, . L. (2025) Urinary incontinence in patients on anti-hypertensive therapy: Insights from a cross-sectional study. Rawal Medical Journal, 50 (2), 270-273.